SciELO - Scientific Electronic Library Online

 
vol.27 número4Abordaje pterional: variaciones técnicas, y resultados funcionales y cosméticos en una serie de 1000 pacientesEvaluation of the Status Epilepticus Severity Score (STESS) as a predictor of in-hospital mortality in patients with status epilepticus: a retrospective observational study índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • No hay artículos similaresSimilares en SciELO

Compartir


Archivos de neurociencias (México)

versión On-line ISSN 2954-4122

Arch. Neurocien. (Mex.) vol.27 no.4 Ciudad de México oct./dic. 2022  Epub 23-Jun-2025

https://doi.org/10.31157/an.v27i4.372 

Original articles

Demand for mental health care in a public psychiatric institution in Mexico City during the COVID-19 pandemic

Héctor Cabello-Rangel1 
http://orcid.org/0000-0002-0421-4351

Jorge Abraham Santiago-Luna2 
http://orcid.org/0000-0002-6092-4112

1Fray Bernardino Álvarez Psychiatric Hospital, Mexico City.

2Unique Program of Medical Specialization in Psychiatry, National Autonomous University of Mexico. Fray Bernardino Álvarez Psychiatric Hospital, Mexico City.


Abstract

Introduction:

The COVID-19 pandemic caused by the SARS-CoV-2 virus has led to a significant increase in the prevalence of mental disorders. Objective: This study aims to compare the demand for mental health care in a public psychiatric hospital in Mexico City during the COVID-19 pandemic.

Methods:

An observational and descriptive study was conducted to analyze the demand for mental health care in the hospital during the second semester of 2019 and 2021.

Results:

A total of 5707 appointments in 2021 were analyzed, revealing a significant reduction in demand by more than 50% compared to 2019 (p=0.009). Additionally, there was a substantial increase in the demand for substance use disorders, depression, and anxiety in 2021, with respective increases of 208%, 275%, and 485% compared to 2019.

Conclusions:

The COVID-19 pandemic has widened the gap in mental health care, likely due to mobility restrictions and the closure of mental health units, which may have hindered access to necessary mental health services.

Keywords: pandemic; mental disorders; service demand; care gap

Introduction

The global prevalence of depression and anxiety is estimated to be 4.4% and 3.6%, respectively, with higher rates among women. In the Americas region, the rates are concentrated at 15% and 21%.1 The COVID-19 pandemic, caused by the SARSCoV-2 virus, has become a trigger for stressful experiences in the general population, leading to the onset or worsening of mental illnesses. Reports have shown an increase in cases of depression, anxiety, psychological distress, and suicidal behavior.2 Following the start of the pandemic in China, there was a rapid increase in negative emotions such as anxiety and depression in the week,3 resulting in a prevalence of 23.8% and 28.8% for depression and anxiety, respectively.4

Over the past few decades, the prevalence of mental disorders in Mexico has been on the rise. According to data from the National Health Survey 2019, 17.9% of adults exhibited depressive symptoms indicative of moderate or severe depression.5 Similarly, there has been an increase in alcohol and illicit substance use before the pandemic.6 The increasing prevalence of mental disorders has had an impact on the demand and supply of mental health services, which is particularly challenging in countries like Mexico where access to these services is limited.7 It is worth noting that the treatment gap for these disorders in Latin American countries can be as high as 80%.8 This study aims to compare the demand for mental health care between June and December in 2019 and 2021 at a public psychiatric hospital in Mexico City.

The Fray Bernardino Álvarez Psychiatric Hospital (HPFBA, for its acronym in Spanish) was the sole medical-psychiatric facility in Mexico City that remained operational throughout the COVID-19 pandemic caused by the SARS-CoV-2 virus.

Method

This study is an observational, descriptive, retrospective comparative study. A non-probabilistic sample was used, consisting of all patient records who sought medical-psychiatric care during the periods of June to December in 2019 and 2021. All patients included in the study were over 18 years of age.

Data Sources

  1. The psychiatric morbidity report from the Biostatistics Service of the HPFBA for the period of June to December 2019 was consulted. This report contains the following data: sex, number of appointments by sex, and diagnostic categories according to the International Classification of Mental and Behavioral Disorders (ICD-10). The diagnostic categories included in the report are: 1) organic mental disorders, 2) mental and behavioral disorders due to psychoactive substance use, 3) schizophrenia, schizotypal, and delusional disorders, 4) bipolar affective disorders, 5) depressive disorders, 6) neurotic, stress-related, and somatoform disorders, 7) personality disorders and behavior disorders in adults, 8) intellectual disability, 9) hyperkinetic disorders, 10) epilepsy.

  2. The database of medical-psychiatric care records from the triage service of the HPFBA for the period of June to December 2021 was consulted. This database contains sociodemographic characteristics (age, sex, place of residence), psychiatric diagnosis according to the ICD-10, and the presence of COVID-19-compatible symptoms. It is important to note that this service started functioning in May 2020 due to the COVID-19 pandemic, but the information was systematized into a database in June 2021. Since the biostatistics service prepares the morbidity report based on the diagnostic categories mentioned above, the diagnoses from the June to December 2021 period were also grouped to compare the variations in demand.

  3. Weekly information on the number of COVID-19 cases in Mexico City during the second half of 2021 was obtained from the daily report by the Federal Government.9

Data analysis

Descriptive statistics, including means, standard deviations, frequencies, and percentages, were employed to summarize the data for each variable. To compare the demand for care between the June-December periods of 2019 and 2021, the psychiatric triage data were categorized based on the diagnostic categories of the ICD-10, and the mean differences were calculated. A significance level of p=<0.05 was considered as the threshold for statistical significance. All statistical analyses were performed using SPSS version 26.

Ethical considerations were duly addressed in this study. The Research Committee of the Fray Bernardino Álvarez Psychiatric Hospital approved the research with registration number CI924-2021. Authorization was obtained from the institution to access, handle, and create the necessary database for the research while ensuring the confidentiality and anonymity of the participants. Informed consent was not required due to the nature of the study.

Results

During the June-December period of 2019, there were a total of 14,602 appointments, with 6,369 requested by males and 8,233 by females. The main reason for consultation was categorized as schizophrenia, schizotypal, and delusional disorders (42.09%), followed by personality disorders (19.5%) and depressive disorders (10.87%) (Table 1).

Table 1 Variations in demand for mental health care between 2019 and 2021 

Demand 2019 Demand 2021 Demand 2019 Demand 2021
Men (n=6369) Women (n=8233) Total (n=14602) Men (n=2614)+ Women (n=3093)+ Total (n= 5707) Variation
n (%) n (%) % n (%) n (%) % %
Diagnosis
Depressive disorders 392 (6.15) 1196 (14.53) 10.87 556 (9.74) 1113 (19.50) 29.94 275.4
Schizophrenia, schizotypal disorders, and delusional disorders 3749 (58.86) 2398 (29.13) 42.09 770 (13.49) 592 (10.37) 23.87 56.7
Neurotic disorders, stress-related disorders, and somatoform disorders 164 (2.57) 305 (3.70) 3.21 366 (6.41) 524 (9.18) 15.59 485.7
Mental and behavioral disorders due to multiple drug use and other psychoactive substance use 460 (7.21) 220 (2.67) 4.65 442 (7.74) 110 (1.93) 9.67 208.0
Personality disorders and adult behavior disorders 461 (7.23) 2387 (28.99) 19.5 162 (2.84) 351 (6.15) 8.99 46.1
Organic mental disorders 379 (5.95) 293 (3.56) 4.6 95 (1.66) 131 (2.30) 3.96 86.1
Bipolar affective disorder 308 (4.84) 667 (8.10) 6.67 57 (1.0) 140 (2.45) 3.45 51.7
Intellectual disability 84 (1.47) 76 (1.33) 2.8
Hyperkinetic disorders 38 (0.67) 8 (0.14) 0.81
Epilepsy 12 (0.21) 26 (0.46) 0.67
Other disorders ** 121 (1.90) 341 (4.14) 3.16 32 (0.65) 22 (0.39) 0.95 30.1
Residence Accumulated
Mexico City sd sd 1632 (28.60) 2095 (36.71) 65.31
State of Mexico sd sd 824 (14.44) 839 (14.70) 94.45
Morelos sd sd 49 (0.89) 54 (0.95) 96.25
Guerrero sd sd 37 (0.65) 27 (0.47) 97.37
Hidalgo sd sd 16 (0.28) 22 (0.39) 98.04
Puebla sd sd 18 (0.32) 14 (0.25) 98.60
Veracruz sd sd 3 (0.05) 10 (0.18) 98.83
Querétaro sd sd 4 (0.07) 8 (0.14) 99.04
Michoacán sd sd 5 (0.09) 5 (0.09) 99.21
Oaxaca sd sd 9 (0.16) 0 (-) 99.37
Other states** sd sd 17 (0.30) 19 (0.33) 100.00

*Includes: psychological developmental disorders; behavioral syndromes associated with physiological disturbances and physical factors; unspecified organic or symptomatic mental disorders; problems related to management; onset and maintenance of sleep disorders; intentional self-harm; problems related to primary support group difficulties; problems related to other psychosocial circumstances.

**Includes population from Oaxaca, Guanajuato, Tlaxcala, Chiapas, Sinaloa, Jalisco, Baja California, Tabasco, Nayarit, Tamaulipas, and Zacatecas; as well as from foreign countries (Chile, El Salvador).

+t = -0.337, p = 0.714 (95% CI -314.0 - 226.9), nd = no data

In the June-December period of 2021, there were a total of 5,707 cases, with a distribution of 2,614 males (45.8%) and 3,093 females (54.2%). The mean age was 37.6 years (SD=15.0; min-max: 18-92) (Table 1). The main reason for consultation during this period was depressive disorders, followed by psychotic disorders, as well as neurotic and stressrelated disorders; another frequent reason was substance use disorders. There were no statistically significant differences between males and females in relation to diagnoses; however, affective disorders (depression and bipolar) and neurotic, stress-related, and somatoform disorders were more common in females. On the other hand, psychotic disorders (schizophrenia, schizotypal disorders, delusional disorders) and substance use disorders were more common in males.

Table 1 shows that there was a significant increase in demand for substance use disorders (208%), depressive disorders (275%), and neurotic disorders (mainly anxiety, 485%) when comparing the two periods. In contrast, there was a decrease of 56.7% in demand for care for patients with schizophrenia and 51.7% for bipolar disorders.

The population seeking care predominantly resided in Mexico City, the State of Mexico, and Morelos, which together accounted for 96.25% of the total. A very low percentage of patients (0.9%) reported symptoms compatible with COVID-19 (Table 1).

When comparing the total demand, it was observed that in 2021, it decreased by more than 50% compared to the same period in 2019 (Table 2); the months of June, September, and November had the most drastic reductions. The differential demand for care was -5,830 appointments, with statistically significant differences (p=<0.05).

Table 2 Comparison of demand for mental health care between 2019 and 2021 

Care demand 2019 Care demand 2021 Differential Daily COVID-19 Cases
Mean (SD) Mean (SD) t(CI 95%)
Total 11570 (1652.8 +/-188) 5740 (676.7+/-) 3.137 (254.3-1411-4)*
June 1395 164 -1231 564
July 1749 2004 255 1607
August 1858 1284 -574 3158
September 1707 333 -1374 1460
October 1837 1145 -692 398
November 1609 323 -1286 176
December 1415 487 -926 607
*p=0.009

When comparing the daily number of COVID-19 cases in Mexico City between June and December 2021 with the demand for care, a notable pattern emerged. It was observed that the demand for care tended to increase during weeks with a higher number of infections. This trend persisted until September and then showed some fluctuations, with irregular increases observed throughout October (see Figure 1).

Figure 1 Variation in demand for care and daily COVID-19 cases. 

Discussion

The June-December period of 2021 witnessed a notable 50% reduction in the total demand for mental health care compared to the same period in 2019. This decline aligns with the 100% reduction in new and subsequent consultations reported by the General Directorate of Health Information in 2020,10 confirming the persistence of this trend throughout 2021.

This decrease in demand can be attributed to mobility restrictions and reduced staff in mental health centers and psychiatric hospitals, which limited access to health services. Similar trends of decreased demand were observed in psychiatric hospitals in Spain, where demand decreased by 58% compared to 2019.11

Despite the overall decrease in demand, certain mental disorders exhibited increasing trends. Depression and anxiety showed a significant increase in demand, with the latter quadrupling. Substance-related disorders also displayed a rising trend. While some studies reported an increase in the prevalence of anxiety disorders during the pandemic, others indicated no significant changes in alcohol consumption.12,13 Furthermore, there was a confirmed increase in the number of mental disorder cases proportionate to the reported rise in COVID-19 infections, consistent with findings from other studies.14

One dire consequence of the lack of mental health care is suicide. Mexico was already experiencing a steady increase in suicide deaths, which was exacerbated by the reduction in mental health services during the pandemic. The demand for care related to depression and anxiety quadrupled, while the demand for psychotic disorders decreased. This likely contributed to the highest number of suicide cases reported since 1994, with 7,896 cases in 2020.15

Another crucial aspect to consider is the accessibility of mental health services. Our results showed that only 65% of individuals seeking care at the hospital were residents of Mexico City, indicating that 35% were unable to receive care in their local areas. This issue should be addressed through policies that aim to enhance actions and improve access to mental health services at the primary care level.16

Conclusions

Based on these findings, it is evident that there has been a reduction in the demand for mental health care and an increase in the demand for depressive and neurotic disorders. Mental health services face significant challenges in addressing this demand and developing strategies to meet the accumulated needs. The findings of this study provide insight into the situation in the country, considering the role of the Fray Bernardino Álvarez Psychiatric Hospital, which attends to approximately 15% of outpatient consultations nationwide7 and remained operational throughout the pandemic. However, further research is necessary to estimate the impact of mobility restrictions and the shortage of mental health professionals (such as doctors, nurses, psychologists, and social workers) in the context of the pandemic. Acknowledgments

The authors would like to thank the authorities of the Fray Bernardino Álvarez Psychiatric Hospital.

Funding

This study did not receive funding from any commercial, academic, or governmental entity.

References

1. Organización Mundial de la Salud. Depresión y otros trastornos mentales comunes Estimaciones sanitarias mundiales [Internet]. Washington: Organización Mundial de la Salud; 2017. https://iris.paho.org/bitstream/handle/10665.2/34006/PAHONMH17005-spa.pdfLinks ]

2. Guo Q, Zheng Y, Shi J, et al. Immediate psychological distress in quarantined patients with COVID-19 and its association with peripheral inflammation: a mixed-method study. Brain Behav Immun. 2020(88):17-27. doi:10.1016/j.bbi.2020.05.038 [ Links ]

3. Li S, Wang Y, Xue J, Zhao N, Zhu T. The impact of COVID-19 epidemic declaration on psychological consequences: A study on active Weibo users. Int J Environ Res Public Health. 2020;17(6): 2032. doi:10.3390/ijerph17062032 [ Links ]

4. Ramirez J, Castro-Quintero D, Lerma-Córdoba C, YelaCeballos F, Escobar-Córdoba F. Mental health consequences of the COVID-19 pandemic associated with social isolation. Colombian Journal of Anesthesiology. 2020; 48(4). doi:10.5554/22562087.e930 [ Links ]

5. Shamah-Levy T, Vielma-Orozco E, Heredia-Hernández O, Romero-Martínez M, Mojica-Cuevas J, Cuevas-Nasu L, et al. Encuesta Nacional de Salud y Nutrición 2018-19: Resultados Nacionales. Cuernavaca: Instituto Nacional de Salud Pública; 2020 Disponible en: http://www.insp.mx/produccion-editorial/novedades-editoriales/ensanut2018-nacionales Comentario a editor: Valencia PD. ¿Es incorrecta la prevalencia de síntomas depresivos presentada en el informe de la Ensanut 2018-19?. Salud Publica Mex [Internet]. 26 de agosto de 2022 [citado 13 de diciembre de 2022]; 64(5):451-2. Disponible en: https://saludpublica. mx/index.php/spm/article/view/13774 [ Links ]

6. Romero-Mendoza M, Meza-Mercado D, Martínez-Martínez R, Magis-Rodríguez C, Ortiz Castro A, Medina-Mora ME. People who inject drugs (PWID) and HIV/aids cases in Mexico City: 1987-2015. Subst Abuse Treat Prev Policy. 2019;14(1). doi:10.1186/s13011-019-0246-x [ Links ]

7. Díaz-Castro L, Cabello-Rangel H, Medina-Mora ME, Berenzon-Gorn S, Robles-García R, Madrigal-de León EA. Mental health care needs and use of services in Mexican population with serious mental disorders. Salud Publica Mex. 2020; 62:72-9. doi:10.21149/10323 [ Links ]

8. Kohn R, Levav I, Caldas de Almeida JM, Vicente B, Andrade L, Caraveo-Anduaga JJ, Saxena S, Saraceno B. Los trastornos mentales en América Latina y el Caribe: asunto prioritario para la salud pública. Rev Panam Salud Publica. 2005;18(4/5):229-40. Disponible en: https://www.bvs.sa.cr/saludmental/28084.pdfLinks ]

9. Secretaria de Economía, Datawheel. Data México [Internet]. Gobierno de México. https://datamexico.org/es/coronavirusLinks ]

10. Dirección General de Información en Salud. Datos en salud [Internet]. Sistema de Información de la Secretaria de Salud [citado 10 mayo 2021]. Disponible en: Disponible en: http://sinaiscap. salud.gob.mx:8080/DGIS/Links ]

11. Solari-Heresmann LM, Pérez-Balaguer A, Gil-Benito E, Sol-Calderón P, Sanz-Aranguez-Ávila B, Gayubo-Moreo L, et al. Analysis of the demand for care in a psychiatric emergency room and an acute inpatient unit in the context of the COVID-19 pandemic. Rev Chil Neuro-Psiquiatr. 2021; 59(1):27-37. http://www.journalofneuropsychiatry.cl/docs/8/49.pdfLinks ]

12. Gaitán-Rossi P, Pérez-Hernández V, Vilar-Compte M, TeruelBelismelis G. Monthly prevalence of generalized anxiety disorder during the COVID-19 pandemic in Mexico. Salud Publica Mex. 2021; 63(4):478-85. doi:10.21149/12257 [ Links ]

13. Manthey J, Carr S, Anderson P, Bautista N, Braddick F, O’Donnell A, et al. Reduced alcohol consumption during the COVID-19 pandemic: Analyses of 17 000 patients seeking primary health care in Colombia and Mexico. J Glob Health. 2022(12); 12:05002. doi:10.7189/jogh.12.05002 [ Links ]

14. Leo Sher. Psychiatric disorders and suicide in the covid-19 era. QJM. 2020;113(8):527-8. doi:10.1093/qjmed/hcaa204 [ Links ]

15. Instituto Nacional de Estadística y Geografía. Demografía y Sociedad: Salud Mental [Internet]. INEGI https://www.inegi.org.mx/temas/salud/Links ]

16. Cámara de Diputados. Comisión de Salud LXV Legislatura. Proyecto de dictamen de la minuta con proyecto de decreto que reforma, adiciona y deroga diversas disposiciones de la Ley General de Salud, en materia de salud mental y adicciones. Ciudad de México: Gaceta Parlamentaria; 2022 http://gaceta.diputados.gob.mx/PDF/65/2022/mar/20220331-IV.pdf#page=2Links ]

Received: May 24, 2022; Accepted: July 05, 2022

Correspondence Héctor Cabello-Rangel Fray Bernardino Álvarez Psychiatric Hospital. Niño Jesús S/N, Col. Barrio Niño Jesús, 14620, Mexico City, Mexico. ✉ hector19.05.19.05@gmail.com

Creative Commons License This is an open-access article distributed under the terms of the Creative Commons Attribution License